2:00-3:45 PM
Sponsored by the Liver Pathobiology Scientific Interest Group
Session Room: TBD
Kari Nejak-Bowen, PhD
University of Pittsburgh School of Medicine
Wen-Xing Ding, PhD
Kansas University Medical Center
Autophagy is a catabolic process that results in clearance of abnormal or damaged proteins and organelles that would otherwise accumulate and lead to cellular stress. In the liver, autophagy also plays an important role in maintaining cellular and metabolic homeostasis by providing nutrients for energy production. Dysregulated autophagy can lead to liver diseases such as metabolic dysfunction-associated steatotic liver disease, drug-induced liver injury, cholestasis, and cancer. This session will explore the molecular mechanisms underlying autophagy, and also discuss how dysregulated hepatic autophagy exacerbates disease. Therapeutic implications of modulating autophagy in liver disease will also be discussed.
Co-Chair – Welcome and Introductions
2:00-2:25 PM
The End is the Beginning: Lessons Learned from TFEB in Alcohol-Associated Liver Disease and Cancer
Wen-Xing Ding, PhD
Kansas University Medical Center
2:25-2:50 PM
Therapeutic Strategies to Enhance Autophagy in Porphyria
Kari Nejak-Bowen, PhD
University of Pittsburgh School of Medicine
2:50-3:15 PM
Exercise Activates Hepatic Autophagy to Mitigate MASH
CongCong He, PhD
Northwestern University
3:15-3:45 PM
Lysosomes in Metabolic Liver Diseases
Ling Yang, PhD
University of Iowa Carver College of Medicine